Indicated Prevention of Psychotic Disorders With Low-dose Lithium
NCT00202306
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Bipolar Disorder
Psychotic Disorders
Interventions
DRUG:
lithium carbonate
Sponsor
Melbourne Health
Collaborators
[object Object]